
|Articles|December 1, 2007
Can studies funded by manufacturers yield valid, objective results?
With the decreases in government funding of medical trials, manufacturers of the products being tested finance more and more clinical trials, whether for medication, therapies or equipment. Tests are obviously needed to determine the effectiveness and safety of new products in order to make medical progress. That system, however, can put unpredictable pressure on physicians conducting the trials.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
CSU With Biochemical C1 Inhibitor Deficiency: Case Report Raises Diagnostic Questions
2
Clinicians Weigh Topical Sequencing and Escalation in Complex Atopic Dermatitis Cases
3
Common Mistakes in Managing Hair Loss and Pigmentary Disorders
4
Sonelokimab Meets Primary End Point in Phase 3 Psoriatic Arthritis Trial
5











